Top Blue Chip Stocks To Buy For 2019

It was a mixed day for stocks as blue chips managed to squeak out a gain and small-caps got crushed ahead of tomorrow’s Fed announcement.

Keith Bedford for The Wall Street Journal

The S&P 500 fell 0.2% to 2,015.93 today, while the Dow Jones Industrial Average rose 22.40 points, or 0.1%, to 17,251.53. The Nasdaq Composite fell 0.5% to 4,728.67. The Russell 2000 tumbled 1.6% to 1,066.67, the first time since Sept. 2011 that the small-company benchmark fell by at least 1.5% and the Dow Jones Industrial Average finished higher.

The folks at Bespoke Investment Group consider the Russell 2000′s underperformance versus the S&P 500 this year:

Including today, the S&P 500 is down 1.6%, while the Russell 2000 is down 6.1%. Todays underperformance in small caps is just a continuation of what has been an extremely consistent trend of daily underperformance this year.

Top Blue Chip Stocks To Buy For 2019: ONEOK Inc.(OKE)

Advisors’ Opinion:

  • [By Max Byerly]

    Bronfman E.L. Rothschild L.P. increased its holdings in ONEOK (NYSE:OKE) by 86.1% in the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 14,456 shares of the utilities provider’s stock after buying an additional 6,690 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in ONEOK were worth $823,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    These are some of the news articles that may have effected Accern’s scoring:

    UBS Upgrades ONEOK (OKE) to “Buy” (americanbankingnews.com) Early Moves to Watch ONEOK Inc (NYSE: OKE) (stocksmarketcap.com) Oneok board increases dividend (journalrecord.com) Deutsche Bank Initiates Coverage on ONEOK (OKE) (americanbankingnews.com) Trading Psychology Agilent Technologies, Inc. (A), ONEOK, Inc. (OKE) (nmsunews.com)

    OKE has been the subject of a number of recent research reports. Zacks Investment Research upgraded ONEOK from a “sell” rating to a “hold” rating in a research report on Friday, December 22nd. Royal Bank of Canada upgraded ONEOK from a “sector perform” rating to an “outperform” rating in a research report on Tuesday, January 16th. TheStreet downgraded ONEOK from a “b” rating to a “c+” rating in a research report on Monday, February 26th. Bank of America initiated coverage on ONEOK in a research report on Tuesday, January 9th. They set a “neutral” rating for the company. Finally, Wells Fargo upgraded ONEOK from a “market perform” rating to an “outperform” rating in a research report on Thursday, January 11th. Ten research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average target price of $61.13.

  • [By Lee Jackson]

    The volatile price of natural gas over the past year has weighed some on this top energy stock. ONEOK Inc. (NYSE: OKE) primarily engages in natural gas transportation, storage and natural gas and NGLs gathering, processing and fractionation in the Bakken, Mid-Continent and Permian. The company recently closed the roll-up of its underlying master limited partnership, ONEOK Partners.

  • [By Matthew DiLallo]

    Energy infrastructure companies ONEOK (NYSE:OKE) and TransCanada (NYSE:TRP) are both emerging from the energy market downturn as stronger entities. Each made smart acquisitions, with TransCanada buying U.S. gas pipeline company Columbia Pipeline Group, while ONEOK is in the process of gobbling up its MLP,ONEOK Partners (NYSE:OKS). While these deals enhanced the growth profiles of both companies, TransCanada still stands out as the better buy for long-term income investors. Here’s why.

Top Blue Chip Stocks To Buy For 2019: Bank of Hawaii Corporation(BOH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Bank of Hawaii Corporation (NYSE: BOH) is expected to report its quarterly earnings at $0.99 per share on revenue of $149.88 million.

    Zions Bancorporation (NASDAQ: ZION) is projected to post its quarterly earnings at $0.39 per share on revenue of $576.49 million.

  • [By Lisa Levin]

    Breaking news

    Hasbro, Inc. (NASDAQ: HAS) reported weaker-than-expected results for its first quarter on Monday.
    Subsea 7 S.A. confirmed a $7.00 per share proposal to acquire McDermott International Inc (NYSE: MDR).
    CenterPoint Energy, Inc. (NYSE: CNP) announced plans to acquire Vectren Corp (NYSE: VVC) for $72 per share in cash.
    Bank of Hawaii Corporation (NYSE: BOH) reported upbeat earnings for its first quarter.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Kimberly-Clark Corporation (NYSE: KMB) is expected to report quarterly earnings at $1.71 per share on revenue of $4.60 billion.
    Halliburton Company (NYSE: HAL) is projected to report quarterly earnings at $0.42 per share on revenue of $5.75 billion.
    Lennox International Inc. (NYSE: LII) is estimated to report quarterly earnings at $1.09 per share on revenue of $815.16 million.
    Alaska Air Group, Inc. (NYSE: ALK) is projected to report quarterly loss at $0.12 per share on revenue of $1.82 billion.
    Hasbro, Inc. (NASDAQ: HAS) is expected to report quarterly earnings at $0.35 per share on revenue of $822.15 million.
    Lincoln Electric Holdings, Inc. (NASDAQ: LECO) is projected to report quarterly earnings at $1.08 per share on revenue of $729.83 million.
    Tennant Company (NYSE: TNC) is estimated to report quarterly earnings at $0.15 per share on revenue of $251.93 million.
    FirstEnergy Corp. (NYSE: FE) is projected to report quarterly earnings at $0.67 per share on revenue of $3.43 billion.
    Koninklijke Philips NV (ADR) (NYSE: PHG) is estimated to report earnings for its first quarter.
    Bank of Hawaii Corporation (NYSE: BOH) is expected to report quarterly earnings at $1.23 per share on revenue of $162.39 million.
    Avangrid, Inc. (NYSE: AGR) is projected to report quarterly earnings at $0.79 per share on revenue of $1.72 billion.

     

Top Blue Chip Stocks To Buy For 2019: Syndax Pharmaceuticals, Inc. (SNDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Several institutional investors have recently bought and sold shares of the company. BVF Inc. IL acquired a new position in shares of Syndax Pharmaceuticals during the 4th quarter worth about $28,326,000. Millennium Management LLC grew its position in shares of Syndax Pharmaceuticals by 18.9% during the 4th quarter. Millennium Management LLC now owns 516,500 shares of the company’s stock worth $4,525,000 after buying an additional 82,256 shares during the period. Geode Capital Management LLC grew its position in shares of Syndax Pharmaceuticals by 17.4% during the 4th quarter. Geode Capital Management LLC now owns 153,483 shares of the company’s stock worth $1,344,000 after buying an additional 22,803 shares during the period. Crestline Management LP grew its position in shares of Syndax Pharmaceuticals by 55.3% during the 4th quarter. Crestline Management LP now owns 83,139 shares of the company’s stock worth $728,000 after buying an additional 29,607 shares during the period. Finally, State Street Corp grew its position in shares of Syndax Pharmaceuticals by 32.8% during the 2nd quarter. State Street Corp now owns 81,327 shares of the company’s stock worth $1,137,000 after buying an additional 20,106 shares during the period. Institutional investors own 69.55% of the company’s stock.

    TRADEMARK VIOLATION WARNING: “Syndax Pharmaceuticals (SNDX) Rating Lowered to D at TheStreet” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/3364448/syndax-pharmaceuticals-sndx-rating-lowered-to-d-at-thestreet.html.

    About Syndax Pharmaceuticals

  • [By Lisa Levin]

    Shares of Syndax Pharmaceuticals Inc (NASDAQ: SNDX) got a boost, shooting up 32 percent to $12.40 after the company reported the advancement of ENCORE 601 in non-small cell lung cancer patients with disease progression on or after PD-1 therapies.

  • [By Chris Lange]

    Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI).

Top Blue Chip Stocks To Buy For 2019: Retail Properties of America, Inc.(RPAI)

Advisors’ Opinion:

  • [By Lee Jackson]

    Retail Properties of America Inc. (NYSE: RPAI) investors receive a 5.7% yield. The stock was last seen trading at $11.45 a share. The 52-week range is $10.94 to $14.70, and the consensus price target is $15.44.

  • [By Ant贸nio Costa]

    Retail Properties of America Inc (NYSE: RPAI) has been in an impressive rebound since the lows of August and the stock price action continues to become Bullish. However, RPAI has run into the downtrend line resistance again and this could lead to a brief period of sideways consolidation or price correction from current levels. On watch.

Top Blue Chip Stocks To Buy For 2019: STARWOOD PROPERTY TRUST, INC.(STWD)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Starwood Property Trust (STWD) is a finance REIT, which means it makes or owns real estate mortgages rather than owning commercial property. The bulk of Starwood Property’s business is to make and hold commercial property mortgages.

Leave a Reply

Your email address will not be published. Required fields are marked *